P
Protalix BioTherapeutics D
D
PLX
2.10000
USD
0.07
(3.19%)
مغلق
حجم التداول
15,182
الربح لكل سهم
0
العائد الربحي
-
P/E
11
حجم السوق
169,200,448
المقالات
العنوان: Protalix BioTherapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
